Prescription of lipid-lowering medications for patients with type 2 diabetes mellitus and risk-associated LDL cholesterol: a nationwide study of guideline adherence from the Swedish National Diabetes Register
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1472-6963
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Prescription of lipid-lowering medications for patients with type 2 diabetes mellitus and risk-associated LDL cholesterol: a nationwide study of guideline adherence from the Swedish National Diabetes Register ; volume:18 ; number:1 ; day:28 ; month:11 ; year:2018 ; pages:1-10 ; date:12.2018
BMC health services research ; 18, Heft 1 (28.11.2018), 1-10, 12.2018
- Urheber
-
Karlsson, Sofia Axia
Franzén, Stefan
Svensson, Ann-Marie
Miftaraj, Mervete
Eliasson, Björn
Andersson Sundell, Karolina
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s12913-018-3707-4
- URN
-
urn:nbn:de:101:1-2019011323584888978652
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
- 14.08.2025, 10:57 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Karlsson, Sofia Axia
- Franzén, Stefan
- Svensson, Ann-Marie
- Miftaraj, Mervete
- Eliasson, Björn
- Andersson Sundell, Karolina
- SpringerLink (Online service)
Ähnliche Objekte (12)
Clinical Considerations for Healthcare Provider-Administered Lipid-Lowering Medications
Longitudinal associations between use of antihypertensive, antidiabetic, and lipid-lowering medications and biological aging
Effect of lipid-lowering medications in patients with coronary artery bypass grafting surgery outcomes
Use of electronic patient data overview with alerts in primary care increases prescribing of lipid-lowering medications in patients with type 2 diabetes
Reasons of general practitioners for not prescribing lipid-lowering medication to patients with diabetes: a qualitative study
Glycaemic Effects of Non-statin Lipid-Lowering Therapies
Lipid-lowering properties of protein-rich mucuna product
Thiazolidinediones: the Forgotten Diabetes Medications
Real-World Effectiveness of Lipid-Lowering Medications on Outcomes after Stroke: Potential Implications of the New-User Design
Impact of Socioeconomic Factors and Gender on Refill Adherence and Persistence to Lipid-Lowering Therapy in Type 1 Diabetes
Association of lipid-lowering drugs with the risk of type 2 diabetes and its complications: a mendelian randomized study
Dyslipidemia, lipid-lowering agents and neuroendocrine neoplasms: new horizons
Clinical Considerations for Healthcare Provider-Administered Lipid-Lowering Medications
Longitudinal associations between use of antihypertensive, antidiabetic, and lipid-lowering medications and biological aging
Effect of lipid-lowering medications in patients with coronary artery bypass grafting surgery outcomes
Use of electronic patient data overview with alerts in primary care increases prescribing of lipid-lowering medications in patients with type 2 diabetes
Reasons of general practitioners for not prescribing lipid-lowering medication to patients with diabetes: a qualitative study
Glycaemic Effects of Non-statin Lipid-Lowering Therapies
Lipid-lowering properties of protein-rich mucuna product
Thiazolidinediones: the Forgotten Diabetes Medications
Real-World Effectiveness of Lipid-Lowering Medications on Outcomes after Stroke: Potential Implications of the New-User Design
Impact of Socioeconomic Factors and Gender on Refill Adherence and Persistence to Lipid-Lowering Therapy in Type 1 Diabetes
Association of lipid-lowering drugs with the risk of type 2 diabetes and its complications: a mendelian randomized study
Dyslipidemia, lipid-lowering agents and neuroendocrine neoplasms: new horizons
Clinical Considerations for Healthcare Provider-Administered Lipid-Lowering Medications
Longitudinal associations between use of antihypertensive, antidiabetic, and lipid-lowering medications and biological aging
Effect of lipid-lowering medications in patients with coronary artery bypass grafting surgery outcomes
Use of electronic patient data overview with alerts in primary care increases prescribing of lipid-lowering medications in patients with type 2 diabetes
Reasons of general practitioners for not prescribing lipid-lowering medication to patients with diabetes: a qualitative study
Glycaemic Effects of Non-statin Lipid-Lowering Therapies
Lipid-lowering properties of protein-rich mucuna product
Thiazolidinediones: the Forgotten Diabetes Medications
Real-World Effectiveness of Lipid-Lowering Medications on Outcomes after Stroke: Potential Implications of the New-User Design
Impact of Socioeconomic Factors and Gender on Refill Adherence and Persistence to Lipid-Lowering Therapy in Type 1 Diabetes
Association of lipid-lowering drugs with the risk of type 2 diabetes and its complications: a mendelian randomized study